Connection

Graham Warren to Male

Back to Details
This is a "connection" page, showing publications Graham Warren has written about Male.
Graham Warren
Connection Strength
0.437
Male
  1. Tobacco and E-cigarette use among cancer survivors in the United States. PLoS One. 2019; 14(12):e0226110.
    View in: PubMed
    Score: 0.037
  2. Identifying Targeted Strategies to Improve Smoking Cessation Support for Cancer Patients. J Thorac Oncol. 2015 Nov; 10(11):1532-7.
    View in: PubMed
    Score: 0.028
  3. Accuracy of self-reported tobacco use in newly diagnosed cancer patients. Cancer Causes Control. 2013 Jun; 24(6):1223-30.
    View in: PubMed
    Score: 0.023
  4. Author's reply to: Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013 Feb 15; 132(4):992.
    View in: PubMed
    Score: 0.022
  5. Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013 Jan 15; 132(2):401-10.
    View in: PubMed
    Score: 0.022
  6. Nicotinic modulation of therapeutic response in vitro and in vivo. Int J Cancer. 2012 Dec 01; 131(11):2519-27.
    View in: PubMed
    Score: 0.022
  7. Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population. Radiother Oncol. 2012 Apr; 103(1):45-8.
    View in: PubMed
    Score: 0.021
  8. Selectively enhanced radiation sensitivity in prostate cancer cells associated with proteasome inhibition. Oncol Rep. 2006 May; 15(5):1287-91.
    View in: PubMed
    Score: 0.014
  9. Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck Cancer. JAMA Netw Open. 2022 12 01; 5(12):e2245818.
    View in: PubMed
    Score: 0.011
  10. The first 20 months of the COVID-19 pandemic: Mortality, intubation and ICU rates among 104,590 patients hospitalized at 21 United States health systems. PLoS One. 2022; 17(9):e0274571.
    View in: PubMed
    Score: 0.011
  11. Associations between cancer diagnosis and patients' responses to an inpatient tobacco treatment intervention. Cancer Med. 2021 08; 10(15):5329-5337.
    View in: PubMed
    Score: 0.010
  12. Negative affect and the utilization of tobacco treatment among adult smokers with cancer. Psychooncology. 2021 01; 30(1):93-102.
    View in: PubMed
    Score: 0.010
  13. European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus?palliative cancer treatment. Eur J Cancer. 2020 10; 138:99-108.
    View in: PubMed
    Score: 0.010
  14. Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 05 01; 146(5):455-464.
    View in: PubMed
    Score: 0.009
  15. An Implementation Trial to Improve Tobacco Treatment for Cancer Patients: Patient Preferences, Treatment Acceptability and Effectiveness. Int J Environ Res Public Health. 2020 03 28; 17(7).
    View in: PubMed
    Score: 0.009
  16. Effects of nicotine exposure on murine mandibular development. PLoS One. 2019; 14(6):e0218376.
    View in: PubMed
    Score: 0.009
  17. Association of Care Processes With Timely, Equitable Postoperative Radiotherapy in Patients With Surgically Treated Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2018 12 01; 144(12):1105-1114.
    View in: PubMed
    Score: 0.009
  18. Effect of an Evidence-based Inpatient Tobacco Dependence Treatment Service on 1-Year Postdischarge Health Care Costs. Med Care. 2018 10; 56(10):883-889.
    View in: PubMed
    Score: 0.008
  19. Evaluation of a Dedicated Tobacco Cessation Support Service for Thoracic Cancer Center Patients. J Public Health Manag Pract. 2018 Sep/Oct; 24(5):E12-E19.
    View in: PubMed
    Score: 0.008
  20. Effect of an Evidence-based Inpatient Tobacco Dependence Treatment Service on 30-, 90-, and 180-Day Hospital Readmission Rates. Med Care. 2018 04; 56(4):358-363.
    View in: PubMed
    Score: 0.008
  21. A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent. Cancer Chemother Pharmacol. 2017 Sep; 80(3):497-505.
    View in: PubMed
    Score: 0.008
  22. A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma. Clin Cancer Res. 2017 Sep 01; 23(17):5055-5065.
    View in: PubMed
    Score: 0.008
  23. The Effects of smoking status and smoking history on patients with brain metastases from lung cancer. Cancer Med. 2017 May; 6(5):944-952.
    View in: PubMed
    Score: 0.008
  24. Subsite variation in survival of oropharyngeal squamous cell carcinomas 2004 to 2011. Laryngoscope. 2017 05; 127(5):1087-1092.
    View in: PubMed
    Score: 0.007
  25. Smoking status and symptom burden in surgical head and neck cancer patients. Laryngoscope. 2017 01; 127(1):127-133.
    View in: PubMed
    Score: 0.007
  26. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation. Laryngoscope. 2016 12; 126(12):2733-2738.
    View in: PubMed
    Score: 0.007
  27. Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical research. Cancer. 2016 06 01; 122(11):1728-34.
    View in: PubMed
    Score: 0.007
  28. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016 Mar 01; 193(5):534-41.
    View in: PubMed
    Score: 0.007
  29. The Validity of Self-reported Recent Smoking in Head and Neck Cancer Surgical Patients. Otolaryngol Head Neck Surg. 2015 Dec; 153(6):990-995.
    View in: PubMed
    Score: 0.007
  30. Tobacco Cessation May Improve Lung Cancer Patient Survival. J Thorac Oncol. 2015 Jul; 10(7):1014-9.
    View in: PubMed
    Score: 0.007
  31. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database. Head Neck. 2014 May; 36(5):694-701.
    View in: PubMed
    Score: 0.006
  32. Small cell carcinoma of the esophagus: a SEER database analysis. Ann Surg Oncol. 2013 Dec; 20(13):4239-44.
    View in: PubMed
    Score: 0.006
  33. Pretreatment weight status and weight loss among head and neck cancer patients receiving definitive concurrent chemoradiation therapy: implications for nutrition integrated treatment pathways. Support Care Cancer. 2013 Oct; 21(10):2825-33.
    View in: PubMed
    Score: 0.006
  34. Prognostic implications of signet ring cell histology in esophageal adenocarcinoma. Cancer. 2013 Sep 01; 119(17):3156-61.
    View in: PubMed
    Score: 0.006
  35. Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes. Arch Intern Med. 2012 Jul 09; 172(13):1005-11.
    View in: PubMed
    Score: 0.005
  36. Quantification of the effect of treatment duration on local-regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck. Head Neck. 2013 May; 35(5):684-8.
    View in: PubMed
    Score: 0.005
  37. Quantification of incidental mediastinal and hilar irradiation delivered during definitive stereotactic body radiation therapy for peripheral non-small cell lung cancer. Med Dosim. 2012; 37(2):182-5.
    View in: PubMed
    Score: 0.005
  38. Evaluation of an intervention to enhance the delivery of smoking cessation services to patients with cancer. J Cancer Educ. 2011 Sep; 26(3):577-82.
    View in: PubMed
    Score: 0.005
  39. Effects of sleep apnea severity on glycemic control in patients with type 2 diabetes prior to continuous positive airway pressure treatment. Diabetes Technol Ther. 2011 Sep; 13(9):945-9.
    View in: PubMed
    Score: 0.005
  40. Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol. 2011 Apr 25; 6:41.
    View in: PubMed
    Score: 0.005
  41. Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy. Head Neck. 2011 Nov; 33(11):1561-8.
    View in: PubMed
    Score: 0.005
  42. The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN. Mol Cancer Ther. 2007 Sep; 6(9):2477-86.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.